Equillium (EQ) Other Non-Current Liabilities (2017 - 2021)
Equillium (EQ) reported Other Non-Current Liabilities of $17000.0 for Q3 2021, down 76.06% year-over-year from $71000.0 in Q3 2020, and little changed on a QoQ basis from $17000.0 in Q2 2021.
Equillium (EQ) has 5 years of Other Non-Current Liabilities data on file, last reported at $17000.0 in Q3 2021.
- Quarterly Other Non-Current Liabilities fell 76.06% year-over-year to $17000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $17000.0 (down 76.06% YoY) and the FY2020 annual result came in at $54000.0, down 57.48% from the prior year.
- Other Non-Current Liabilities held at $17000.0 in Q3 2021 per EQ's latest filing, from $17000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $775842.0 in Q4 2017 and bottomed at $17000.0 in Q2 2021.
- The 5-year median for Other Non-Current Liabilities is $99000.0 (2020), against an average of $149130.5.
- The widest annual swing landed in 2019, when Other Non-Current Liabilities dropped 1.83%; it then sank 81.11% in 2021.
- Tracing EQ's Other Non-Current Liabilities over 5 years: stood at $775842.0 in 2017, then tumbled by 74.22% to $200000.0 in 2018, then sank by 36.5% to $127000.0 in 2019, then tumbled by 57.48% to $54000.0 in 2020, then plunged by 68.52% to $17000.0 in 2021.
- Per Business Quant, the three latest EQ Other Non-Current Liabilities figures stand at $17000.0 (Q3 2021), $17000.0 (Q2 2021), and $35000.0 (Q1 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Equillium | 279.21 Mn | 218.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 17,000.00 |
| Jun 30, 2021 | 17,000.00 |
| Mar 31, 2021 | 35,000.00 |
| Dec 31, 2020 | 54,000.00 |
| Sep 30, 2020 | 71,000.00 |
| Jun 30, 2020 | 90,000.00 |
| Mar 31, 2020 | 108,000.00 |
| Dec 31, 2019 | 127,000.00 |
| Sep 30, 2019 | 146,000.00 |
| Dec 31, 2018 | 200,000.00 |
| Sep 30, 2018 | 148,724.00 |
| Dec 31, 2017 | 775,842.00 |